| Drs. Hamel And Waldorf | |
|
132 Old River Rd Ste 201, Lincoln, RI 02865-1158 | |
| (401) 721-5599 | |
| (401) 721-5597 |
| Full Name | Drs. Hamel And Waldorf |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 132 Old River Rd Ste 201, Lincoln, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437348505 | NPI | - | NPPES |
| 9007801 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | ODTA00468 (Rhode Island) | Primary |
| Provider Name | Carol J Hamel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437214004 PECOS PAC ID: 3375688468 Enrollment ID: I20100301000302 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Impax Laboratories, Inc. today announced that it has initiated litigation against Shire LLC and Shire Laboratories, Inc. ("Shire") in order to resolve recent and recurring supply issues of its authorized generic version of Adderall XR®. The Company is seeking to compel Shire to deliver duly ordered amounts of product under the parties' Settlement Agreement and License and Distribution Agreements.
While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.
› Verified 8 days ago
| Provider Name | Greg Waldorf |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1386709947 PECOS PAC ID: 1759355845 Enrollment ID: I20120330000065 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Impax Laboratories, Inc. today announced that it has initiated litigation against Shire LLC and Shire Laboratories, Inc. ("Shire") in order to resolve recent and recurring supply issues of its authorized generic version of Adderall XR®. The Company is seeking to compel Shire to deliver duly ordered amounts of product under the parties' Settlement Agreement and License and Distribution Agreements.
While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Drs. Hamel And Waldorf 132 Old River Rd, Ste 201, Lincoln, RI 02865-1161 Ph: (401) 721-5599 | Drs. Hamel And Waldorf 132 Old River Rd Ste 201, Lincoln, RI 02865-1158 Ph: (401) 721-5599 |
News Archive
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
Impax Laboratories, Inc. today announced that it has initiated litigation against Shire LLC and Shire Laboratories, Inc. ("Shire") in order to resolve recent and recurring supply issues of its authorized generic version of Adderall XR®. The Company is seeking to compel Shire to deliver duly ordered amounts of product under the parties' Settlement Agreement and License and Distribution Agreements.
While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.
› Verified 8 days ago
Dr. Lawrence Sumner Cohen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 620 George Washington Hwy, Target Optical, Lincoln, RI 02864 Phone: 401-642-0080 Fax: 508-923-9894 | |
Dr. Steven A Croce I, Optometrist Medicare: May Accept Medicare Assignments Practice Location: 622 George Washington Hwy, Lincoln, RI 02865 Phone: 401-333-0550 Fax: 401-312-0083 | |
Croce And Pugliese Vision Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 622 George Washington Hwy, Lincoln Mall, Lincoln, RI 02865 Phone: 401-333-0550 Fax: 401-312-0083 | |
Greg Ross Waldorf, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 132 Old River Rd Ste 201, Lincoln, RI 02865 Phone: 401-721-5599 Fax: 401-721-5597 | |
Carol J Hamel, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 132 Old River Rd Ste 201, Lincoln, RI 02865 Phone: 401-721-5599 Fax: 401-721-5597 | |
Eyes On Lincoln Llc Optometrist Medicare: Medicare Enrolled Practice Location: 622 George Washington Hwy, Lincoln, RI 02865 Phone: 401-333-0550 |